1. Among the information provided by applicants, confidential treatment may be given toThe applicant may submit a request to treat certain parts of the information the disclosure of which might significantly harm their competitive position.
Information relating to the following shall not, in any circumstances, be regarded as confidential:
(a) the name and address of the applicant;
(b) the name and a clear description of the substance;
(c) the justification for the use of the substance in or on specific foodstuffs or food categories;
(d) information that is relevantsubmitted under this Regulation as confidential, accompanied by verifiable justification, upon submission of the application.
2. Where an opinion by the Authority is required in accordance with Article 3(2) of this Regulation, the Authority shall assess the confidentiality request submitted by the applicant, in accordance with Articles 39 to 39e of Regulation (EC) No 178/2002.
3. In addition to the assessment of the safety of the substance;
(e) where applicable, the analysis method(s).
2. For the purposes of implementing paragraph 1, applicants shall indicate which of the information provided they wish to be treated as confidential. Verifiable justification must be given in items of information referred to in Article 39(2) of Regulation (EC) No 178/2002 and pursuant to Article 39(3) thereof, the Authority may also grant confidential treatment with respect to the following items of information, where the disclosure of such cases.
3. The Commission shall decide after consulting with the applicants which information can remain confidential and shall notify applicants and the Member States accordingly.
4. After being made aware of the Commission’s position, applicants shall have three weeks in which to withdraw their application so as to preserve the confidentiality information is demonstrated by the applicant to potentially harm its interests to a significant degree:
(a) where applicable, information provided in detailed descriptions of starting substances and starting preparations and on how they are used to manufacture the substance subject to the authorisation, and detailed information on the nature and composition of the information provided. Confidentiality shall be preserved until this period expires.
5. The Commission, the Authority and the Member States shall, in accordance with Regulation (EC) No 1049/2001, take the necessary measures to ensure appropriate confidentiality of the information received by them under this Regulationmaterials or products in which the applicant intends to use the substance subject to the authorisation, except for information which is relevant to the assessment of safety;
(b) where applicable, detailed analytical information on the variability and stability of individual production batches of the substance subject to the authorisation, except for information which must be made public if circumstances so require in order to protect human health, animal health or the environment.
6. If an applicant withdraws, or has withdrawn, its application, is relevant to the assessment of safety.
4. Where an opinion by the Authority is not required in accordance with Article 3(2) of this Regulation, the Commission, the Authority and the Member States shall not disclose confidential information, including information the confidentiality of which is the subject of disagreement between the Commission and the applicant.
7. The implementation of paragraphs 1 to 6 shall assess the confidentiality request submitted by the applicant. Articles 39, 39a and 39d of Regulation (EC) No 178/2002 and paragraph 3 of this Article shall not affect the circulation of information between the Commission, the Authority and the Member Statesapply mutatis mutandis.
5. This Article is without prejudice to Article 41 of Regulation (EC) No 178/2002.